Strategies for the Management of Spike Protein-Related Pathology

In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis.

[1]  Theresa A Lawrie,et al.  The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review , 2023, J.

[2]  E. Topol,et al.  Long COVID: major findings, mechanisms and recommendations , 2023, Nature Reviews Microbiology.

[3]  D. Barouch,et al.  Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters , 2023, The New England journal of medicine.

[4]  A. Randolph,et al.  Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis , 2023, Circulation.

[5]  David M. Liebovitz,et al.  Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up , 2022, medRxiv.

[6]  A. Nowacki,et al.  Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine , 2022, medRxiv.

[7]  Zhirong Sun,et al.  Ginger supplement significantly reduced length of hospital stay in individuals with COVID-19 , 2022, Nutrition and Metabolism.

[8]  Folker Meyer,et al.  Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro , 2022, BMC Biology.

[9]  Lisa M. Domke,et al.  Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination , 2022, Clinical Research in Cardiology.

[10]  M. Tosato,et al.  Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial , 2022, Nutrients.

[11]  D. Cardinali,et al.  Possible Application of Melatonin in Long COVID , 2022, Biomolecules.

[12]  K. Mølbak,et al.  Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark , 2022, Nature Communications.

[13]  Aseem Malhotra.  Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine - Part 1 , 2022, Journal of Insulin Resistance.

[14]  E. Gurzenda,et al.  Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk. , 2022, JAMA pediatrics.

[15]  Mohamed Reda Ramadan Gomaa,et al.  Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment , 2022, Inflammopharmacology.

[16]  B. Bao,et al.  The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19 , 2022, Antioxidants.

[17]  F. Leung,et al.  Associations of habitual fish oil use with risk of SARS-CoV-2 infection and COVID-19-related outcomes in UK: national population based cohort study , 2022, medRxiv.

[18]  Carolina Q. Sacramento,et al.  Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases , 2022, International Journal of Biological Macromolecules.

[19]  Marc T. Law,et al.  Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study , 2022, The Lancet Child & Adolescent Health.

[20]  R. Suzuki,et al.  Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2 , 2022, Molecules.

[21]  A. Kapoor,et al.  SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Vali Musazadeh,et al.  The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms , 2022, Biomedicine & Pharmacotherapy.

[23]  Andreas C. Themistocleous,et al.  Acute small fiber neuropathy after Oxford‐AstraZeneca ChAdOx1‐S vaccination: A report of three cases and review of the literature , 2022, Journal of the peripheral nervous system.

[24]  S. Kanchanasurakit,et al.  Use of Andrographis paniculata (Burm.f.) Wall. ex Nees and risk of pneumonia in hospitalised patients with mild coronavirus disease 2019: A retrospective cohort study , 2022, Frontiers in Medicine.

[25]  Jingjing Lu,et al.  Cold exposure‐induced endoplasmic reticulum stress regulates autophagy through the SIRT2/FoxO1 signaling pathway , 2022, Journal of cellular physiology.

[26]  D. Kell,et al.  Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) , 2022, Cardiovascular Diabetology.

[27]  James A. White,et al.  Natural History of Myocardial Injury After COVID-19 Vaccine–Associated Myocarditis , 2022, Canadian Journal of Cardiology.

[28]  Ronald B. Brown.  Low dietary sodium potentially mediates COVID-19 prevention associated with whole-food plant-based diets , 2022, British Journal of Nutrition.

[29]  Zezhong Tian,et al.  Protective effects of konjac glucomannan on gut microbiome with antibiotic perturbation in mice. , 2022, Carbohydrate polymers.

[30]  Chuanwu Zhu,et al.  Effect of garlic essential oil in 97 patients hospitalized with covid-19: A multi-center experience. , 2022, Pakistan journal of pharmaceutical sciences.

[31]  A. Nasrullah,et al.  COVID-19 Vaccine and Long COVID: A Scoping Review , 2022, Life.

[32]  B. Trimarco,et al.  Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey , 2022, Pharmacological Research.

[33]  Wipawadee Yooin,et al.  A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery , 2022, Molecules.

[34]  J. Lambert,et al.  Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study , 2022, Brain, Behavior, & Immunity - Health.

[35]  M. Hinescu,et al.  Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination , 2022, Biomedicines.

[36]  M. Holter,et al.  Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients , 2022, Antioxidants.

[37]  G. Lippi,et al.  Homocysteine in coronavirus disease (COVID-19): a systematic literature review , 2022, Diagnosis.

[38]  P. Sengupta,et al.  N-acetyl cysteine as a potential regulator of SARS-CoV-2-induced male reproductive disruptions , 2022, Middle East Fertility Society Journal.

[39]  M. Hernán,et al.  Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans. , 2022, JAMA internal medicine.

[40]  M. Heinrich,et al.  Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial , 2022, Frontiers in Pharmacology.

[41]  Farzam Khokhar,et al.  Small Fiber Neuropathy Associated With the Moderna SARS-CoV-2 Vaccine , 2022, Cureus.

[42]  E. Spisni,et al.  Wheat Germ Spermidine and Clove Eugenol in Combination Stimulate Autophagy In Vitro Showing Potential in Supporting the Immune System against Viral Infections , 2022, Molecules.

[43]  Seyed-Amir Tabatabaeizadeh.  Zinc supplementation and COVID-19 mortality: a meta-analysis , 2022, European Journal of Medical Research.

[44]  C. Maertens de Noordhout,et al.  Pathophysiology and mechanism of long COVID: a comprehensive review , 2022, Annals of medicine.

[45]  K. Khunti,et al.  Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study , 2022, BMJ.

[46]  A. Mainous,et al.  The Impact of Initial COVID-19 Episode Inflammation Among Adults on Mortality Within 12 Months Post-hospital Discharge , 2022, Frontiers in Medicine.

[47]  M. D'Arcy.  A review of biologically active flavonoids as inducers of autophagy and apoptosis in neoplastic cells and as cytoprotective agents in non‐neoplastic cells , 2022, Cell biology international.

[48]  J. Trygg,et al.  Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections , 2022, mBio.

[49]  Yuan Zhang,et al.  Structural complexity of Konjac glucomannan and its derivatives governs the diversity and outputs of gut microbiota. , 2022, Carbohydrate polymers.

[50]  S. Younes,et al.  A Focused Insight into Thyme: Biological, Chemical, and Therapeutic Properties of an Indigenous Mediterranean Herb , 2022, Nutrients.

[51]  G. Layec,et al.  The Influence of Covid‐19‐Based mRNA Vaccines on Measures of Conduit Artery and Microvascular Endothelial Function , 2022, The FASEB Journal.

[52]  K. Hayashida,et al.  Modifiable Host Factors for the Prevention and Treatment of COVID-19: Diet and Lifestyle/Diet and Lifestyle Factors in the Prevention of COVID-19 , 2022, Nutrients.

[53]  K. Kraft,et al.  Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C , 2022, Frontiers in Pharmacology.

[54]  A. Hensel,et al.  Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2 , 2022, Pharmaceuticals.

[55]  M. Brenner,et al.  Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial , 2022, Current neuropharmacology.

[56]  T. Härkänen,et al.  SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents , 2022, JAMA cardiology.

[57]  M. Rodríguez-Moran,et al.  Magnesium-to-Calcium Ratio and Mortality from COVID-19 , 2022, Nutrients.

[58]  T. Borody,et al.  Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity , 2022, BMJ open gastroenterology.

[59]  G. Muscogiuri,et al.  Vitamin D: A Role Also in Long COVID-19? , 2022, Nutrients.

[60]  S. Dutta,et al.  Role of the Microbiome in the Pathogenesis of COVID-19 , 2022, Frontiers in Cellular and Infection Microbiology.

[61]  Folker Meyer,et al.  Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 variants of concern by HMOX-1 upregulation in human cells , 2022, bioRxiv.

[62]  J. Sejvar,et al.  Neurological Events Reported after COVID‐19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System , 2022, Annals of Neurology.

[63]  Nourin Shakeeb,et al.  Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR , 2022, Inflammopharmacology.

[64]  G. Thomas,et al.  The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2 , 2022, International journal of molecular sciences.

[65]  D. Cuthbertson,et al.  Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study , 2022, medRxiv.

[66]  B. Horne,et al.  Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry , 2022, medRxiv.

[67]  D. Harats,et al.  Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron , 2022, The New England journal of medicine.

[68]  N. Skoetz,et al.  Inhaled corticosteroids for the treatment of COVID-19. , 2022, The Cochrane database of systematic reviews.

[69]  J. Sejvar,et al.  Neurological Events Reported after COVID-19 Vaccines: An Analysis of VAERS. , 2022, Annals of neurology.

[70]  Jessie Hawkins,et al.  Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy levels in post-COVID-19 female patients: A randomized, double-blinded, placebo controlled clinical trial , 2022, Complementary Therapies in Medicine.

[71]  M. Mokhtari,et al.  An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19 , 2022, International Journal of Biological Macromolecules.

[72]  T. Shimabukuro,et al.  Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe , 2022, The Lancet Infectious Diseases.

[73]  B. Abdelazeem,et al.  The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials. , 2022, Drug discoveries & therapeutics.

[74]  K. Dhama,et al.  Molecular Docking studies of Apigenin, Kaempferol, and Quercetin as potential target against spike receptor protein of SARS COV , 2022, Journal of Experimental Biology and Agricultural Sciences.

[75]  M. Mohamed,et al.  Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches , 2022, Plants.

[76]  M. Rasmussen,et al.  Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line , 2022, Current issues in molecular biology.

[77]  Arunandan Kumar,et al.  Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic , 2022, Antioxidants.

[78]  D. Kell,et al.  A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications , 2022, The Biochemical journal.

[79]  J. Gill,et al.  Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose. , 2022, Archives of Pathology & Laboratory Medicine.

[80]  C. Chakraborty,et al.  A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations , 2022, Frontiers in Immunology.

[81]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[82]  D. Woo,et al.  Contemporary Trends in the Nationwide Incidence of Primary Intracerebral Hemorrhage , 2022, Stroke.

[83]  G. Hindricks,et al.  National mortality data for Germany before and throughout the pandemic: There is an excess mortality exceeding COVID-19-attributed fatalities , 2022, Journal of Infection.

[84]  Jing Tian,et al.  Populations in Low-Magnesium Areas Were Associated with Higher Risk of Infection in COVID-19’s Early Transmission: A Nationwide Retrospective Cohort Study in the United States , 2022, Nutrients.

[85]  M. Vinceti,et al.  Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies , 2022, Journal of Trace Elements in Medicine and Biology.

[86]  Candace W. Burton,et al.  Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection , 2022, The Journal for Nurse Practitioners.

[87]  Jihye Lee,et al.  Inhibition of ACE2‐Spike Interaction by an ACE2 Binder Suppresses SARS‐CoV‐2 Entry , 2022, Angewandte Chemie.

[88]  C. Chao,et al.  Efficacy of melatonin in the treatment of patients with COVID‐19: A systematic review and meta‐analysis of randomized controlled trials , 2022, Journal of medical virology.

[89]  Jordi Espadaler Mazo,et al.  Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial , 2022, Gut microbes.

[90]  P. Dilokthornsakul,et al.  Potential effects of propolis and honey in COVID-19 prevention and treatment: A systematic review of in silico and clinical studies , 2022, Journal of Integrative Medicine.

[91]  Mark M. Davis,et al.  Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination , 2022, Cell.

[92]  Maciej Banach,et al.  Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials , 2022, Nutrients.

[93]  D. Rhoda,et al.  Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19) , 2021, Scientific Reports.

[94]  Xu-li Zhao,et al.  Ozone induces autophagy by activating PPARγ/mTOR in rat chondrocytes treated with IL-1β , 2020, Journal of Orthopaedic Surgery and Research.

[95]  Z. Engindeniz,et al.  Evaluation of Deltoid Exercises on Injection Site and Arm Pain after BNT162b2 COVID–19 Vaccination, a Randomized Controlled Study , 2022, Social Science Research Network.

[96]  OUP accepted manuscript , 2022, European Heart Journal.

[97]  A. Banerjee,et al.  Nigellidine (Nigella sativa, black-cumin seed) docking to SARS CoV-2 nsp3 and host inflammatory proteins may inhibit viral replication/transcription and FAS-TNF death signal via TNFR 1/2 blocking , 2021, Natural product research.

[98]  A. Zaidi,et al.  The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review , 2021, The Journal of Antibiotics.

[99]  P. Hammarström,et al.  Amyloidogenesis of SARS-CoV-2 Spike Protein , 2021, bioRxiv.

[100]  K. Khunti,et al.  Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection , 2021, Nature Medicine.

[101]  R. Savani,et al.  SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway , 2021, eLife.

[102]  A. Chater,et al.  The Influence of a blend of Probiotic Lactobacillus and Prebiotic Inulin on the Duration and Severity of Symptoms among Individuals with Covid-19 , 2021, Infectious Diseases Diagnosis & Treatment.

[103]  Asma Aktar,et al.  A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV , 2021, Frontiers in Pharmacology.

[104]  A. S. Ethayathulla,et al.  Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants , 2021, Cellular and Molecular Life Sciences.

[105]  N. Goel,et al.  Systemic corticosteroids for management of 'long-COVID': an evaluation after 3 months of treatment. , 2021, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[106]  P. Thacker.  Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial , 2021, BMJ.

[107]  H. Wei,et al.  Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection , 2021, Journal of Advanced Research.

[108]  C. Annweiler,et al.  Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1 , 2021, Nutrients.

[109]  P. Gurbel,et al.  Further evidence for the use of aspirin in COVID-19 , 2021, International Journal of Cardiology.

[110]  L. Leite-Lais,et al.  Nutritional risk of vitamin D, vitamin C, zinc, and selenium deficiency on risk and clinical outcomes of COVID-19: A narrative review , 2021, Clinical Nutrition ESPEN.

[111]  H. Hawley,et al.  Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis , 2021, Medicina.

[112]  Jin-fang Xu,et al.  Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines , 2021, Cell discovery.

[113]  S. Raha,et al.  Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses , 2021, Journal of Neuroimmune Pharmacology.

[114]  T. Fleming,et al.  Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer–BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines , 2021, The Journal of Immunology.

[115]  R. Deschenes,et al.  Inhibition of SARS-CoV-2 spike protein palmitoylation reduces virus infectivity , 2021, bioRxiv.

[116]  M. Farzan,et al.  Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.

[117]  C. Dawid,et al.  In Vitro Effect of Taraxacum officinale Leaf Aqueous Extract on the Interaction between ACE2 Cell Surface Receptor and SARS-CoV-2 Spike Protein D614 and Four Mutants , 2021, Pharmaceuticals.

[118]  M. Taraban,et al.  All vials are not the same: Potential role of vaccine quality in vaccine adverse reactions , 2021, Vaccine.

[119]  Eun-Ju Lee,et al.  SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients , 2021, Blood.

[120]  Z. Taghipour,et al.  Cinnamon and its possible impact on COVID-19: The viewpoint of traditional and conventional medicine , 2021, Biomedicine & Pharmacotherapy.

[121]  T. Zuo,et al.  Gut Microbiome Alterations in COVID-19 , 2021, Genomics, Proteomics & Bioinformatics.

[122]  R. Thimmulappa,et al.  Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19 , 2021, Journal of Pharmaceutical Analysis.

[123]  H. Önal,et al.  Treatment of COVID-19 patients with quercetin: a prospective, single center, randomized, controlled trial , 2021, Turkish journal of biology = Turk biyoloji dergisi.

[124]  V. Bucci,et al.  Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID , 2021, JCI insight.

[125]  D. Kiel,et al.  Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era , 2021, Journal of the American Geriatrics Society.

[126]  A. Robicsek,et al.  Myocarditis and Pericarditis After Vaccination for COVID-19. , 2021, JAMA.

[127]  C. Clapp,et al.  The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling , 2021, bioRxiv.

[128]  I. Laher,et al.  An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations , 2021, Molecules.

[129]  H. Buchholz,et al.  Age- and Sex-Graded Data Evaluation of Vaccination Reactions after Initial Injection of the BNT162b2 mRNA Vaccine in a Local Vaccination Center in Germany , 2021, Vaccines.

[130]  Kam Y. J. Zhang,et al.  A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor , 2021, Drugs in R&D.

[131]  J. S. Coggan,et al.  A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19 , 2021, Frontiers in Public Health.

[132]  P. Edison,et al.  Long covid—mechanisms, risk factors, and management , 2021, BMJ.

[133]  D. Vojta,et al.  Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit , 2021, Frontiers in Endocrinology.

[134]  C. Hopkins,et al.  Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. , 2021, The Cochrane database of systematic reviews.

[135]  Y. Nibu,et al.  Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro , 2021, Biochemical and Biophysical Research Communications.

[136]  L. Vaca,et al.  SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants , 2021, Frontiers in Immunology.

[137]  Geradius Deogratias,et al.  Luteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics , 2021, Journal of Molecular Modeling.

[138]  K. Wong,et al.  N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence , 2021, Journal of inflammation research.

[139]  I. Tleyjeh,et al.  Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19 , 2021, Frontiers in Immunology.

[140]  L. Cooper,et al.  Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. , 2021, JAMA cardiology.

[141]  C. Chakraborty,et al.  Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activity , 2021, Reviews in Medical Virology.

[142]  T. Triche,et al.  Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection , 2021, bioRxiv.

[143]  J. Finley,et al.  The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa , 2021, Plant Foods for Human Nutrition.

[144]  A. Desai,et al.  Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration , 2021, Vaccine.

[145]  M. VanElzakker,et al.  Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms , 2021, Frontiers in Microbiology.

[146]  T. Dowswell,et al.  Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines , 2021, American journal of therapeutics.

[147]  U. Pöschl,et al.  Ceylon cinnamon and its major compound Cinnamaldehyde can limit overshooting inflammatory signaling and angiogenesis in vitro: implications for COVID-19 treatment , 2021, bioRxiv.

[148]  M. Leo,et al.  SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity , 2021, Frontiers in Cardiovascular Medicine.

[149]  Xiaojian Yao,et al.  Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry , 2021, PloS one.

[150]  M. Gobbi,et al.  Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? , 2021, Biomolecules.

[151]  Susan Cheng,et al.  Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case–control study in six countries , 2021, BMJ nutrition, prevention & health.

[152]  William T. Harvey,et al.  SARS-CoV-2 variants, spike mutations and immune escape , 2021, Nature Reviews Microbiology.

[153]  S. Kaleci,et al.  COVID‐19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence , 2021, Journal of clinical laboratory analysis.

[154]  D. Kell,et al.  Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin , 2021, Cardiovascular Diabetology.

[155]  D. Walt,et al.  Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[156]  P. Doshi.  Covid-19 vaccines: In the rush for regulatory approval, do we need more data? , 2021, BMJ.

[157]  G. Jiang,et al.  Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses , 2021, Signal Transduction and Targeted Therapy.

[158]  S. Ramos,et al.  Curcumin as a Potential Treatment for COVID-19 , 2021, Frontiers in Pharmacology.

[159]  P. Anand,et al.  Review the safety of Covid-19 mRNA vaccines: a review , 2021, Patient Safety in Surgery.

[160]  G. S. Zamudio,et al.  Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2 , 2021, Scientific Reports.

[161]  K. Kehn-Hall,et al.  Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2 , 2021, Pathogens & immunity.

[162]  C. Röcken,et al.  First case of postmortem study in a patient vaccinated against SARS-CoV-2 , 2021, International Journal of Infectious Diseases.

[163]  B. Bay,et al.  Chronic cold exposure induces autophagy to promote fatty acid oxidation, mitochondrial turnover, and thermogenesis in brown adipose tissue , 2021, iScience.

[164]  A. Politis,et al.  Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue , 2021, BioFactors.

[165]  V. Karalis,et al.  Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens , 2021, Xenobiotica; the fate of foreign compounds in biological systems.

[166]  Lanjuan Li,et al.  Six-month follow-up of gut microbiota richness in patients with COVID-19 , 2021, Gut.

[167]  A. Speciale,et al.  Silibinin as potential tool against SARS‐Cov‐2: In silico spike receptor‐binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects , 2021, Phytotherapy research : PTR.

[168]  G. Screaton,et al.  Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine , 2021, ACS central science.

[169]  O. Witzke,et al.  Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease , 2021, Viruses.

[170]  K. Kraft,et al.  Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue , 2021, Nutrients.

[171]  A. Malhotra,et al.  SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 , 2021, Circulation research.

[172]  V. Roviello,et al.  Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility , 2021, Molecules.

[173]  A. Keech,et al.  Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials. , 2021, European heart journal.

[174]  A. Coppola,et al.  Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients , 2021, Clinical chemistry and laboratory medicine.

[175]  F. Grosveld,et al.  A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies , 2021, Nature Communications.

[176]  D. Kell,et al.  SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19 , 2021, medRxiv.

[177]  A. García-Sastre,et al.  Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model , 2021, mBio.

[178]  A. Mukherjee,et al.  Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach , 2021, Virusdisease.

[179]  J. Fröhlich-Nowoisky,et al.  Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases , 2021, Frontiers in Plant Science.

[180]  H. Kunugi,et al.  Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies , 2021, Molecules.

[181]  A. Gomaa,et al.  The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions , 2021, Phytomedicine Plus.

[182]  B. Padhy,et al.  Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study , 2021, PloS one.

[183]  J. M. Sforcin,et al.  Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment , 2021, The Journal of pharmacy and pharmacology.

[184]  Rahul Aggarwal,et al.  Colchicine use in patients with COVID-19: A systematic review and meta-analysis , 2021, medRxiv.

[185]  C. Schwartz,et al.  Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro , 2021, Viruses.

[186]  A. Eid,et al.  Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders , 2021, Molecules.

[187]  Asaf Tzachor,et al.  Photosynthetically Controlled Spirulina, but Not Solar Spirulina, Inhibits TNF-α Secretion: Potential Implications for COVID-19-Related Cytokine Storm Therapy , 2021, Marine biotechnology.

[188]  Chaoran Chen,et al.  The effects of metformin on autophagy. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[189]  A. B. Jena,et al.  Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies , 2021, Scientific reports.

[190]  J. Finsterer,et al.  Antiviral activity of Brazilian Green Propolis extract against SARS-CoV-2 (Severe Acute Respiratory Syndrome - Coronavirus 2) infection: case report and review , 2021, Clinics.

[191]  Kazuo Suzuki,et al.  Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients , 2021, Pulmonary Pharmacology & Therapeutics.

[192]  N. Patel,et al.  SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice , 2021, Nature Communications.

[193]  K. Chow,et al.  Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 , 2021, Gut.

[194]  A. Mandal,et al.  N-acetyl cysteine: A tool to perturb SARS-CoV-2 spike protein conformation , 2021 .

[195]  R. Rottier,et al.  SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site , 2021, eLife.

[196]  O. Gülcü,et al.  Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use , 2021, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[197]  Hui Poh Goh,et al.  Licorice: A Potential Herb in Overcoming SARS-CoV-2 Infections , 2021, Journal of evidence-based integrative medicine.

[198]  G. Nuovo,et al.  Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein , 2020, Annals of Diagnostic Pathology.

[199]  N. Jha,et al.  Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19? , 2020, Heliyon.

[200]  Jue Wang,et al.  Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro , 2020, Life Sciences.

[201]  P. Marik,et al.  Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 , 2020, American journal of therapeutics.

[202]  J. Sonnenburg,et al.  Gut Microbiota-Targeted Diets Modulate Human Immune Status , 2020, bioRxiv.

[203]  P. Calder,et al.  Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019? , 2020, Nutrition.

[204]  P. Guest,et al.  Cinnamon: A Promising Natural Product Against COVID-19. , 2021, Advances in experimental medicine and biology.

[205]  M. Fajri.  The potential of Moringa oleifera as immune booster against COVID 19 , 2021, IOP Conference Series: Earth and Environmental Science.

[206]  A. Grover,et al.  Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin , 2020, Journal of biomolecular structure & dynamics.

[207]  P. Ball.  The lightning-fast quest for COVID vaccines — and what it means for other diseases , 2020, Nature.

[208]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[209]  M. Abu-Farha,et al.  Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism , 2020, Frontiers in Pharmacology.

[210]  S. Borwornpinyo,et al.  Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives , 2020, bioRxiv.

[211]  T. Fatma,et al.  Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2 , 2020, Biomedical Journal.

[212]  Yoonkyung Park,et al.  Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit. , 2020, ACS applied materials & interfaces.

[213]  A. Butte,et al.  Identification of antiviral antihistamines for COVID-19 repurposing , 2020, Biochemical and Biophysical Research Communications.

[214]  Sucheta Khubber,et al.  Garlic (Allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19 , 2020, Nutrition Journal.

[215]  Min Li,et al.  Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor , 2020, Computational and Structural Biotechnology Journal.

[216]  Zhongcheng Shi,et al.  N-Acetylcysteine to Combat COVID-19: An Evidence Review , 2020, Therapeutics and clinical risk management.

[217]  P. Moseley,et al.  Autophagy and heat: a potential role for heat therapy to improve autophagic function in health and disease. , 2020, Journal of applied physiology.

[218]  R. Squitti,et al.  Zinc and COVID-19: Basis of Current Clinical Trials , 2020, Biological Trace Element Research.

[219]  J. Diedrich,et al.  Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate , 2020, Science.

[220]  A. Andrews,et al.  The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier , 2020, Neurobiology of Disease.

[221]  A. D'Angelo,et al.  A role for quercetin in coronavirus disease 2019 (COVID‐19) , 2020, Phytotherapy research : PTR.

[222]  Cassandra Willyard.  How anti-ageing drugs could boost COVID vaccines in older people , 2020, Nature.

[223]  F. Reis,et al.  Gut Microbiota Dysbiosis–Immune Hyperresponse–Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches , 2020, Microorganisms.

[224]  Lixia Chen,et al.  Furin: A Potential Therapeutic Target for COVID-19 , 2020, iScience.

[225]  K. Bacharı,et al.  Potential therapeutic effects of Resveratrol against SARS-CoV-2. , 2020, Acta virologica.

[226]  F. Guilford,et al.  Glutathione Supplementation as an Adjunctive Therapy in COVID-19 , 2020, Antioxidants.

[227]  L. Kong,et al.  Possibility of magnesium supplementation for supportive treatment in patients with COVID-19 , 2020, European Journal of Pharmacology.

[228]  R. Leduc,et al.  Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract – A review of patent literature , 2020, Expert opinion on therapeutic patents.

[229]  Shenmin Zhang,et al.  SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 , 2020, Journal of Hematology & Oncology.

[230]  M. Karst,et al.  Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? , 2020, Medical Hypotheses.

[231]  D. De Jong,et al.  Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease , 2020, Biomedicine & Pharmacotherapy.

[232]  J. van Paassen,et al.  Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes , 2020, Critical Care.

[233]  A. Oladiji,et al.  Kolaviron (Kolaflavanone), apigenin, fisetin as potential Coronavirus inhibitors: In silico investigation , 2020 .

[234]  F. Midulla,et al.  Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases , 2020, Infection.

[235]  H. Schuitemaker,et al.  Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses , 2020, npj Vaccines.

[236]  Rebecca J. Loomis,et al.  Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates , 2020, The New England journal of medicine.

[237]  Michael A. Joseph,et al.  The impact of obesity on COVID-19 complications: a retrospective cohort study , 2020, International Journal of Obesity.

[238]  F. Violi,et al.  Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? , 2020, Drugs.

[239]  Debnath Utsab,et al.  Conformational Perturbation of SARS-CoV-2 Spike Protein Using N-Acetyl Cysteine, a Molecular Scissor: A Probable Strategy to Combat COVID-19 , 2020 .

[240]  Zigui Chen,et al.  Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19 , 2020, Gut.

[241]  S. Del Prato,et al.  COVID-19 in people with diabetes: understanding the reasons for worse outcomes , 2020, The Lancet Diabetes & Endocrinology.

[242]  V. Bhardwaj,et al.  Fish oil and COVID-19 thromboses , 2020, Journal of Vascular Surgery: Venous and Lymphatic Disorders.

[243]  T. Madhavan,et al.  Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein , 2020, Journal of Molecular Structure.

[244]  Francesco Castelli,et al.  Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics , 2020, The Lancet Infectious Diseases.

[245]  G. Pescarmona,et al.  The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19 , 2020, Antioxidants.

[246]  N. Maideen.  Prophetic Medicine-Nigella Sativa (Black cumin seeds) – Potential herb for COVID-19? , 2020, Journal of pharmacopuncture.

[247]  Mohammad Tariqur Rahman.  Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19 , 2020, Journal of Herbal Medicine.

[248]  Chitra Jeyaraj Pandian,et al.  Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials , 2020, Journal of biomolecular structure & dynamics.

[249]  B. Medhi,et al.  Naltrexone a potential therapeutic candidate for COVID-19 , 2020, Journal of biomolecular structure & dynamics.

[250]  K. Damevska,et al.  Back to the basics: Propolis and COVID‐19 , 2020, Dermatologic therapy.

[251]  M. Menegazzi,et al.  Can Hypericum perforatum (SJW) prevent cytokine storm in COVID‐19 patients? , 2020, Phytotherapy research : PTR.

[252]  M. M. Donma,et al.  The effects of allium sativum on immunity within the scope of COVID-19 infection , 2020, Medical Hypotheses.

[253]  N. Rezaei,et al.  Interleukin-6 and severe COVID-19: a systematic review and meta-analysis , 2020, European Cytokine Network.

[254]  A. Rafique,et al.  Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life? , 2020, JAMA network open.

[255]  W. Banks,et al.  Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation , 2020, International journal of molecular sciences.

[256]  Pei-Jer Chen,et al.  Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects , 2020, Cell Reports.

[257]  A. Polonikov.  Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients , 2020, ACS infectious diseases.

[258]  Alex Brito,et al.  Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis , 2020, Nutrients.

[259]  G. Padmanaban,et al.  Comparative Docking Studies on Curcumin with COVID-19 Proteins , 2020 .

[260]  D. Lynn,et al.  The non-specific and sex-differential effects of vaccines , 2020, Nature Reviews Immunology.

[261]  M. Roser,et al.  Coronavirus Pandemic (COVID-19) , 2020 .

[262]  Maciej Banach,et al.  Potential effects of curcumin in the treatment of COVID‐19 infection , 2020, Phytotherapy research : PTR.

[263]  W. Chan,et al.  Flow Rate Affects Nanoparticle Uptake into Endothelial Cells , 2020, Advanced materials.

[264]  Xiangxi Wang,et al.  Development of an inactivated vaccine candidate for SARS-CoV-2 , 2020, Science.

[265]  G. Castaldo,et al.  Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2) , 2020, Molecules.

[266]  M. Hoffmann,et al.  A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.

[267]  T. Theoharides.  COVID‐19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin , 2020, BioFactors.

[268]  Aroni Chatterjee,et al.  Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development , 2020, Journal of biomolecular structure & dynamics.

[269]  D. Jans,et al.  The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro , 2020, Antiviral Research.

[270]  F. Wolf,et al.  The COVID-19 pandemic: is there a role for magnesium? Hypotheses and perspectives. , 2020, Magnesium research.

[271]  Duong Tuan Quang,et al.  Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil , 2020, ACS omega.

[272]  Shibo Jiang,et al.  Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine , 2020, Cellular & Molecular Immunology.

[273]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[274]  B. Canard,et al.  The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade , 2020, Antiviral Research.

[275]  Harshita,et al.  Lipid-based nanoformulations in the treatment of neurological disorders , 2020, Drug metabolism reviews.

[276]  R. Valentine,et al.  Acute Heat Exposure Alters Autophagy Signaling in C2C12 Myotubes , 2020, Frontiers in Physiology.

[277]  Fang Li,et al.  Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry , 2019, Journal of Virology.

[278]  M. Manoharan,et al.  The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs , 2019, Nature Nanotechnology.

[279]  S. Brandhorst,et al.  Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity , 2019, Advances in nutrition.

[280]  G. Salazar,et al.  Protective Role of Polyphenols against Vascular Inflammation, Aging and Cardiovascular Disease , 2018, Nutrients.

[281]  G. Barreto,et al.  The effect of fasting or calorie restriction on autophagy induction: A review of the literature , 2018, Ageing Research Reviews.

[282]  Carlo Follo,et al.  The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells , 2017, Molecular carcinogenesis.

[283]  Yu-Chiang Hung,et al.  Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke , 2017, Oxidative medicine and cellular longevity.

[284]  Barney S. Graham,et al.  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.

[285]  C. Weng,et al.  Natural Compounds from Herbs that can Potentially Execute as Autophagy Inducers for Cancer Therapy , 2017, International journal of molecular sciences.

[286]  Sylvia Voegeli,et al.  Multiplexed gene control reveals rapid mRNA turnover , 2017, Science Advances.

[287]  M. Amato,et al.  Chia seeds products: an overview , 2017, Phytochemistry Reviews.

[288]  Kimberly J. Hassett,et al.  Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[289]  D. Faraoni,et al.  Randomized controlled trials vs. observational studies: why not just live together? , 2016, BMC Anesthesiology.

[290]  Fang Li,et al.  Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.

[291]  A. Read,et al.  Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens , 2015, PLoS biology.

[292]  Joseph F. Clark,et al.  A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles , 2015, Scientific Reports.

[293]  B. Ozpolat,et al.  Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer , 2014, Cell Death and Disease.

[294]  C. Isidoro,et al.  Single Amino Acid Arginine Deprivation Triggers Prosurvival Autophagic Response in Ovarian Carcinoma SKOV3 , 2014, BioMed research international.

[295]  M. Maiuri,et al.  Coffee induces autophagy in vivo , 2014, Cell cycle.

[296]  Y. Belkaid,et al.  Role of the Microbiota in Immunity and Inflammation , 2014, Cell.

[297]  Mark P Mattson,et al.  Fasting: molecular mechanisms and clinical applications. , 2014, Cell metabolism.

[298]  T. Schlake,et al.  Developing mRNA-vaccine technologies , 2012, RNA biology.

[299]  S. Clissold.  Aspirin and Related Derivatives of Salicylic Acid , 2012, Drugs.

[300]  M. Bondì,et al.  Lipid nanoparticles for drug targeting to the brain. , 2012, Methods in enzymology.

[301]  Thomas D. Pollard,et al.  A Guide to Simple and Informative Binding Assays , 2010, Molecular biology of the cell.

[302]  Jincun Zhao,et al.  A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry , 2010, Journal of Virology.

[303]  Bernhard H Weigl,et al.  Laboratory operations, specimen processing, and handling for viral load testing and surveillance. , 2010, The Journal of infectious diseases.

[304]  Xi-qing Sun,et al.  Hyperbaric oxygen preconditioning reduces ischemia–reperfusion injury by stimulating autophagy in neurocyte , 2010, Brain Research.

[305]  Frank Sinner,et al.  Induction of autophagy by spermidine promotes longevity , 2009, Nature Cell Biology.

[306]  J. Steinberger,et al.  Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. , 2009, Journal of the American Dietetic Association.

[307]  R. Chen,et al.  Amyloid-degrading ability of nattokinase from Bacillus subtilis natto. , 2009, Journal of agricultural and food chemistry.

[308]  A. van Hoof,et al.  Messenger RNA regulation: to translate or to degrade , 2008, The EMBO journal.

[309]  Claire Williams,et al.  Impact of consuming a milk drink containing a probiotic on mood and cognition , 2007, European Journal of Clinical Nutrition.

[310]  Tin-Yun Ho,et al.  Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction , 2006, Antiviral Research.

[311]  J. Brodsky,et al.  Autophagy: an ER Protein Quality Control Process , 2006, Autophagy.

[312]  K. Kashiwagi,et al.  Decrease in polyamines with aging and their ingestion from food and drink. , 2006, Journal of biochemistry.

[313]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[314]  P. Aaby,et al.  The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. , 2004, International journal of epidemiology.

[315]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[316]  A. Asada,et al.  Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. , 1993, Biochemical and biophysical research communications.

[317]  荒井保明.  Pharmacokinetics , 1993 .

[318]  A. Herman,et al.  Nutmeg oil: identification and quantitation of its most active constituents as inhibitors of platelet aggregation. , 1990, Journal of ethnopharmacology.

[319]  J. Gillette.  Problems in Correlating In Vitro and In Vivo Studies of Drug Metabolism , 1984 .

[320]  B. Osterud,et al.  The clotting time of whole blood in plastic tubes: the influence of exercise, prostacyclin and acetylsalicylic acid. , 1983, Thrombosis research.

[321]  S. Nitter‐Hauge,et al.  Thromboembolic Complications in Coronary Angiography , 1977, Acta radiologica: diagnosis.

[322]  JoVE Video Dataset , 2022 .